- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05544188
Functional Pathologies of the Musculoskeletal System in Physiotherapy Students (FUNPAMUS)
January 19, 2026 updated by: Kamila Řasová, Charles University, Czech Republic
Occurrence and Characteristics of Functional Pathologies of the Musculoskeletal System in Physiotherapy Students and the Possibility of Influencing Them
This study map the occurrence of functional pathologies of the musculoskeletal system in students of the bachelor's program of physiotherapy of the Third Faculty of Medicine, Charles University, and aim on improvement of them.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The aim of this study is to map the occurrence of functional pathologies of the musculoskeletal system in students of the bachelor's program of physiotherapy of the Third Faculty of Medicine, Charles University, and to examine their postural functions.
Another goal is to teach the students of the experimental group how to remove functional pathologies of the musculoskeletal system and how to change their motor behaviour and postural functions so that the development of functional disorders no longer occurs.
Study Type
Interventional
Enrollment (Actual)
44
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Prague, Czechia
- Department of rehabilitation, Third Faculty of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 26 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Bachelor's study of physiotherapy at the Third Faculty of Medicine, Charles University
- The presence of functional pathologies of the musculoskeletal system (verification by means of Trigger Points)
Exclusion Criteria:
- Serious cardiovascular or orthopedic dysfunction
- Neurological disease
- Reduced cognitive functions complicating examination and subsequent therapy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: individual outpatient physiotherapy
individual outpatient physiotherapy (7 times in two and a half months, approx.
90 minutes) aimed at correcting functional pathologies of the musculoskeletal system assessed by differential diagnosis (removal of trigger points, stretching of shortened muscles and mobilization of joint blockages) and changing of motor program that led to the occurrence of the functional disorder by means of Motor Programmes Activating Therapy
|
Physiotherapy aimed at correcting functional pathologies of the musculoskeletal system assessed by differential diagnosis (removal of trigger points, stretching of shortened muscles and mobilization of joint blockages)
|
|
Active Comparator: Without changing the current habits
It will not change the existing habits.
At the same time, however, these are physiotherapy students who will participate in the classes.
Their motor behaviour can thus be influenced in a natural way.
|
Physiotherapy aimed at correcting functional pathologies of the musculoskeletal system assessed by differential diagnosis (removal of trigger points, stretching of shortened muscles and mobilization of joint blockages)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in Trigger Points at 3 months
Time Frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three months).
|
Local hypertonic change in muscle function arising as a manifestation of pathogenic tension, 0 no trigger point, 2 maximal tiger point (higher value, worse function)
|
Pre-assessment (baseline testing), Post-assessment (immediately after the end of three months).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in the Foot posture index at 3 and 15 month
Time Frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three months), Follow up (at 15 months).
|
Clinical examination of the foot type ranging from significantly pronated (values 6 - 12) to significantly supinated (values from -1 to -12) one according to the 6-item, higher value (both negative or positive) means worse function.
|
Pre-assessment (baseline testing), Post-assessment (immediately after the end of three months), Follow up (at 15 months).
|
|
Change in Foot morphology and flexibility at 3 and 15 month
Time Frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three months), Follow up (at 15 months).
|
examination by means of the full foot 3D scanner Footscan® and the software 3D scanner 7.7 while sitting and standing still.
Arch high index defines two kinds of pathologies: hypermobility under 0,6, norm 0,7 - 0,8, rigidity 0,9 - 1,3
|
Pre-assessment (baseline testing), Post-assessment (immediately after the end of three months), Follow up (at 15 months).
|
|
Change in Postural stability at 3 and 15 month
Time Frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three months), Follow up (at 15 months).
|
evaluation of the level of postural stability using the total path of displacement of the centre of pressure of the body on the mat in mm and the maximum displacement obtained in the latero-lateral and in the anteroposterior direction in mm (lower number means better function), measurement using the RS Footscan® tensiometric plate, higher value means worse function.
|
Pre-assessment (baseline testing), Post-assessment (immediately after the end of three months), Follow up (at 15 months).
|
|
Change in the subtalar joint flexibility at 3 and 15 month
Time Frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three months), Follow up (at 15 months).
|
mobility of the subtalar joint during the initial phase of walking (software evaluation after walking barefoot on the Footscan® tensiometric plate).
Under 5.5° means normal range of pronation and normal function.
Higher values mean worse function and pathologic pronation during initial phase of gait.
|
Pre-assessment (baseline testing), Post-assessment (immediately after the end of three months), Follow up (at 15 months).
|
|
Change in the foot progression angle at 3 and 15 month
Time Frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three months), Follow up (at 15 months).
|
rotation of the foot during walking (software evaluation after walking barefoot on the Footscan® tensiometric plate).
Normal angle 0-5.4°, in-toeing (inwards rotation) under 0°, out-toeing (outward rotation) above 5.5°.
|
Pre-assessment (baseline testing), Post-assessment (immediately after the end of three months), Follow up (at 15 months).
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Kamila Rasova, Third Faculty of Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2022
Primary Completion (Actual)
May 30, 2025
Study Completion (Actual)
May 30, 2025
Study Registration Dates
First Submitted
September 14, 2022
First Submitted That Met QC Criteria
September 14, 2022
First Posted (Actual)
September 16, 2022
Study Record Updates
Last Update Posted (Actual)
January 21, 2026
Last Update Submitted That Met QC Criteria
January 19, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 29072022
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.